# EXELON
> **NDA020823** · New Drug Application · Sponsor: NOVARTIS · Approved 2000-04-21
## Drug
- **FDA Application Number:** NDA020823
- **Application type:** New Drug Application
- **Brand name:** EXELON
- **Generic name:** Rivastigmine Tartrate
- **Active ingredients:** RIVASTIGMINE TARTRATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVARTIS
- **First approval:** 2000-04-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020823)
---
*MORVS · CC0 1.0*